Explore

Trendline Trendline
Lunai Bioworks and BrainStorm Therapeutics Collaborate on AI-Driven Neurology Drug Discovery

Lunai Bioworks and BrainStorm Therapeutics Collaborate on AI-Driven Neurology Drug Discovery

Lunai Bioworks and BrainStorm Therapeutics Collaborate on AI-Driven Neurology Drug Discovery
Trendline Trendline
Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment

Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment

Acurex Biosciences Secures ASAP Grant to Innovate Parkinson's Disease Treatment
Trendline Trendline
EpiWatch App Shows Promise in Detecting Seizures with Minimal False Alarms

EpiWatch App Shows Promise in Detecting Seizures with Minimal False Alarms

EpiWatch App Shows Promise in Detecting Seizures with Minimal False Alarms
Trendline Trendline
Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Revenue Opportunity

Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Revenue Opportunity

Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Revenue Opportunity
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Market Opportunity

Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Market Opportunity

Reid Hoffman Highlights AI's Potential in Drug Discovery as Next Major Market Opportunity
Trendline Trendline
Bonito Biosciences and DaltonTx Partner to Enhance Oligotherapeutic Delivery

Bonito Biosciences and DaltonTx Partner to Enhance Oligotherapeutic Delivery

Bonito Biosciences and DaltonTx Partner to Enhance Oligotherapeutic Delivery
Trendline Trendline
FDA Extends Review Period for Beren Therapeutics' Drug for Rare Disease

FDA Extends Review Period for Beren Therapeutics' Drug for Rare Disease

FDA Extends Review Period for Beren Therapeutics' Drug for Rare Disease
Trendline Trendline
GeneDx to Present at Goldman Sachs Healthcare Conference, Highlighting Genomic Advancements

GeneDx to Present at Goldman Sachs Healthcare Conference, Highlighting Genomic Advancements

GeneDx to Present at Goldman Sachs Healthcare Conference, Highlighting Genomic Advancements
Trendline Trendline
Acurex Biosciences Secures ASAP Grant for Parkinson’s Disease Research

Acurex Biosciences Secures ASAP Grant for Parkinson’s Disease Research

Acurex Biosciences Secures ASAP Grant for Parkinson’s Disease Research
Trendline Trendline
28bio Launches CNS-3D Alzheimer's Model to Enhance Therapeutic Predictions

28bio Launches CNS-3D Alzheimer's Model to Enhance Therapeutic Predictions

28bio Launches CNS-3D Alzheimer's Model to Enhance Therapeutic Predictions
Trendline Trendline
IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference

IDEAYA Biosciences to Participate in 2026 Jefferies Global Healthcare Conference